ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      85.17
      0.45%
      Bitcoin
      64,905.02
      -0.36%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Arno Therapeutics Inc (CE) (ARNI)

      7. Arno Therapeutics Inc (CE) (ARNI) News

      ARNI

      Arno Therapeutics (CE) (ARNI)

      Arno Therapeutics Inc (CE)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:ARNI
      DateTimeSourceHeadlineSymbolCompany
      05/15/20144:15PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ARNIArno Therapeutics Inc (CE)
      05/15/20146:07AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARNIArno Therapeutics Inc (CE)
      05/15/20146:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARNIArno Therapeutics Inc (CE)
      05/14/20145:00PMGlobeNewswire Inc.Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...USOTC:ARNIArno Therapeutics Inc (CE)
      05/05/20148:30AMGlobeNewswire Inc.Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual MeetingUSOTC:ARNIArno Therapeutics Inc (CE)
      04/07/201410:42AMGlobeNewswire Inc.Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...USOTC:ARNIArno Therapeutics Inc (CE)
      04/01/20149:10AMGlobeNewswire Inc.Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational MilestonesUSOTC:ARNIArno Therapeutics Inc (CE)
      03/31/20144:58PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ARNIArno Therapeutics Inc (CE)
      03/31/20144:54PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ARNIArno Therapeutics Inc (CE)
      03/31/20144:53PMEdgar (US Regulatory)Annual Report (10-k)USOTC:ARNIArno Therapeutics Inc (CE)
      03/26/20148:45AMGlobeNewswire Inc.Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014...USOTC:ARNIArno Therapeutics Inc (CE)
      03/24/20144:01PMGlobeNewswire Inc.Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice ChairmanUSOTC:ARNIArno Therapeutics Inc (CE)
      03/05/20148:45AMGlobeNewswire Inc.Arno Therapeutics to Present at 26th Annual ROTH ConferenceUSOTC:ARNIArno Therapeutics Inc (CE)
      03/04/20144:40PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ARNIArno Therapeutics Inc (CE)
      03/04/20148:31AMGlobeNewswire Inc.Arno Therapeutics Granted Exclusive License for Oncology Diagnostic Technique by University of MinnesotaUSOTC:ARNIArno Therapeutics Inc (CE)
      02/27/201410:00AMGlobeNewswire Inc.Arno Therapeutics Appoints Lawrence A. Kenyon Chief Financial OfficerUSOTC:ARNIArno Therapeutics Inc (CE)
      02/14/20149:35AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARNIArno Therapeutics Inc (CE)
      02/12/20146:13AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARNIArno Therapeutics Inc (CE)
      01/21/201412:06PMGlobeNewswire Inc.Arno Therapeutics Enrolls First Patient in a Phase I Trial to Evaluate Lead Compound Onapristone in Progesterone Receptor Pos...USOTC:ARNIArno Therapeutics Inc (CE)
      01/13/20148:15AMGlobeNewswire Inc.Arno Therapeutics Expands Management Team With Additions of Two Scientific LeadersUSOTC:ARNIArno Therapeutics Inc (CE)
      01/09/20148:30AMGlobeNewswire Inc.Arno Therapeutics to Present at Biotech Showcase 2014USOTC:ARNIArno Therapeutics Inc (CE)
      01/07/20148:15AMGlobeNewswire Inc.Arno Therapeutics Selects Leica Biosystems to Develop Companion Diagnostic for Targeted Oncology Therapy OnapristoneUSOTC:ARNIArno Therapeutics Inc (CE)
      12/14/20138:30AMGlobeNewswire Inc.Arno Therapeutics to Present Data on Two Potential Predictive Biomarkers at the San Antonio Breast Cancer Symposium 2013USOTC:ARNIArno Therapeutics Inc (CE)
      11/18/20139:27AMGlobeNewswire Inc.Arno Therapeutics Adds Steven Rubin, EVP of OPKO Health, Inc., as Board ObserverUSOTC:ARNIArno Therapeutics Inc (CE)
      11/13/20132:32PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARNIArno Therapeutics Inc (CE)
      11/08/20134:57PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARNIArno Therapeutics Inc (CE)
      11/08/20134:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20136:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:51PMEdgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:ARNIArno Therapeutics Inc (CE)
      11/06/20134:51PMEdgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:ARNIArno Therapeutics Inc (CE)
       Showing the most relevant articles for your search:USOTC:ARNI